Clinical Trials Logo

Clinical Trial Summary

Ovarian cryopreservation is one of the available option for preserving fertility prior to potentially sterilizing treatments. In the absence of other techniques such as in vitro folliculogenesis or injection of isolated ovarian follicles, this tissue can only be re-used by autograft. In France, the first live birth after orthotopic ovarian transplantation, was obtained by Roux et al. in 2009. This clinical trial aims to collect data on the efficiency of the graft in terms of restoration of ovarian function and live births. It will also allow us to carry out the patient follow-up after ovarian tissue cryopreservation and after autograft when achieved. In cases of neoplastic malignancies, minimal residual disease detection will be performed on ovarian tissue, to avoid any risk of cancer re-seeding.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02846064
Study type Interventional
Source Centre Hospitalier Universitaire de Besancon
Contact Clotilde AMIOT, MD PhD
Phone +33381218681
Email clotilde.amiot@univ-fcomte.fr
Status Recruiting
Phase N/A
Start date October 2013
Completion date October 2022

See also
  Status Clinical Trial Phase
Unknown status NCT01782807 - Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy N/A
Completed NCT00429494 - GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients Phase 2
Recruiting NCT02855827 - Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft
Recruiting NCT05330130 - Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells Phase 1
Completed NCT05489367 - Does COVÄ°D-19 m-RNA Vaccine Affect Fertility and Over Reserve ?